Finland· FI-REL-REL41797

Evarrest

A lokale hämostatika, kombinationen product containing fibrinogen + human thrombin, registered in Finland by Omrix Biopharmaceuticals SA/NV. The same ATC class is registered in 11 of our 19 countries.

ATC B02BC30

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEvarrestATCB02BC30REGISTER NO.FI-REL-REL41797PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Lokale hämostatika, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Lokale hämostatika, kombinationen · ATC B02BC30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
FIBRINOGEN + Human thrombin
Manufacturer
Omrix Biopharmaceuticals SA/NV
Country
Finland (FI)
ATC code
B02BC30
ATC class
Lokale Hämostatika, Kombinationen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lokale hämostatika, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lokale hämostatika, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/208f81eb-6ff7-4555-9c61-3a71ac8fdea4
GET /v1/drugs/208f81eb-6ff7-4555-9c61-3a71ac8fdea4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "kudosliimamatriksi",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "yhdistelmävalmisteet",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/13/868/001-02",
  "fimea_rel_id": "REL41797",
  "authorised_at": "2013-09-25"
}

See everything about lokale hämostatika, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.